HUTCHMED (China) (HMDCF) Cash & Equivalents Growth (5y) (2019 - 2025)

HUTCHMED (China) (HMDCF) Cash & Equivalents Growth (5y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 HUTCHMED (China) - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.73%
Jun 30, 2025 -1.79%
Dec 31, 2024 4.56%
Jun 30, 2024 27.75%
Dec 31, 2023 -73.41%
Jun 30, 2023 32.98%
Dec 31, 2022 0.31%
Jun 30, 2022 42.55%
Dec 31, 2021 32.38%
Jun 30, 2021 25.41%
Dec 31, 2020 25.48%
Jun 30, 2020 25.48%
Dec 31, 2019 17.18%